Perspectives on the Management of Oligometastatic Disease in Esophago-Gastric Cancer.

ABSTRACT: Gastric adenocarcinoma and esophageal cancer are the fifth and seventh most common cancer types worldwide. At the time of initial diagnosis, up to 50% of esophagogastric cancers present with distant metastatic lesions and are candidates for chemotherapy. Curative surgery in this stage is still an experimental approach. Only a small number of these metastatic patients show an oligometastatic disease with no uniform definition of what oligometastatic means in gastric cancer. Nevertheless, the question remains unanswered as to whether these patients are still candidates for curative concepts. Some studies have attempted to answer this question but have not been adequately designed to address the role of a curative-intended multimodal therapy in this setting. The current FLOT-5 is designed to

SUBMITTER: Goetze TO 

PROVIDER: S-EPMC9658190 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature